GR79236B - - Google Patents

Info

Publication number: GR79236B
Authority: GR; Greece
Prior art keywords: alpha interferon; gene; taught; expressed; amino acid
Prior art date: 1982-05-28

Application number

GR71447A

Other languages

English (en)

Inventor

E Dr Dworkin-Rastl

M Dr Dworkin

M Gunter Dr Adolf

P Dr Meindl

G Dr Bodo

P Dr Swetly

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-05-28

Filing date

1983-05-24

Publication date

1984-10-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6164725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR79236(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1983-05-24 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1984-10-22 Publication of GR79236B publication Critical patent/GR79236B/el

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/142—Interferon

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Computational Biology (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Crystallography & Structural Chemistry (AREA)
Toxicology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

GR71447A 1982-05-28 1983-05-24 GR79236B (el)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19823220116 DE3220116A1 (de)	1982-05-28	1982-05-28	Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung

Publications (1)

Publication Number	Publication Date
GR79236B true GR79236B (el)	1984-10-22

Family

ID=6164725

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR71447A GR79236B (el)	1982-05-28	1983-05-24

Country Status (22)

Country	Link
US (1)	US4820638A (el)
EP (1)	EP0095702B1 (el)
JP (2)	JPH0774238B2 (el)
KR (1)	KR920006349B1 (el)
AT (1)	ATE42114T1 (el)
AU (1)	AU565479B2 (el)
DD (1)	DD211359C4 (el)
DE (2)	DE3220116A1 (el)
DK (1)	DK164742C (el)
ES (2)	ES8403522A1 (el)
FI (1)	FI82072C (el)
GR (1)	GR79236B (el)
HK (1)	HK112893A (el)
HU (1)	HU196452B (el)
IL (1)	IL68790A (el)
MX (1)	MX9202815A (el)
NO (1)	NO168538C (el)
NZ (1)	NZ204384A (el)
SG (1)	SG38692G (el)
SU (1)	SU1346048A3 (el)
UA (1)	UA8037A1 (el)
ZA (1)	ZA833845B (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3247922A1 (de) *	1982-12-24	1984-06-28	Boehringer Ingelheim International GmbH, 6507 Ingelheim	Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
DE3515336C2 (de) *	1985-04-27	1994-01-20	Boehringer Ingelheim Int	Verfahren zur Herstellung und Reinigung von â-Interferon
US4709324A (en) *	1985-11-27	1987-11-24	Motorola, Inc.	Data processor control unit having an interrupt service using instruction prefetch redirection
CA2025180A1 (en) *	1989-10-12	1991-04-13	William G. Weisburg	Nucleic acid probes and methods for detecting pathogenic candida yeasts
US6685933B1 (en)	1998-07-28	2004-02-03	The United States Of America As Represented By The Department Of Health And Human Services	Interferon α hybrids
JP4220235B2 (ja) *	2000-11-03	2009-02-04	インターシアセラピューティクス，インコーポレイティド	短期及び長期の薬剤薬量決定のための方法
FR2817559B1 (fr) *	2000-12-06	2003-12-12	Genodyssee	Procede de determination d'un ou plusieurs polymorphisme(s) fontionnel(s) dans la sequence nucleique d'un gene "candidat" fonctionnel preselectionne et ses applications
FR2821625B1 (fr) *	2001-03-01	2003-05-16	Genodyssee	Nouveaux polynucleotides comportant un polymorphisme de type snp fonctionnel dans la sequence nucleotidique du gene ifn-alpha-2 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
FR2823220B1 (fr) *	2001-04-04	2003-12-12	Genodyssee	Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
EP1536839B1 (en) *	2001-11-09	2010-09-15	Intarcia Therapeutics, Inc	Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus
US20040063912A1 (en) *	2002-03-15	2004-04-01	The Brigham And Women's Hospital, Inc.	Central airway administration for systemic delivery of therapeutics
WO2003099320A1 (en)	2002-05-24	2003-12-04	Zensun (Shanghai) Sci-Tech.Ltd	Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
WO2004022593A2 (en) *	2002-09-09	2004-03-18	Nautilus Biotech	Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
CA2553034A1 (en)	2004-02-02	2005-08-18	Ambrx, Inc.	Modified human interferon polypeptides and their uses
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
DE602007009377D1 (de)	2006-05-30	2010-11-04	Intarcia Therapeutics Inc	Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
EP2359808B1 (en)	2006-08-09	2013-05-22	Intarcia Therapeutics, Inc	Osmotic delivery systems and piston assemblies
US20080260820A1 (en) *	2007-04-19	2008-10-23	Gilles Borrelly	Oral dosage formulations of protease-resistant polypeptides
AU2008244523B2 (en)	2007-04-23	2012-02-16	Intarcia Therapeutics, Inc.	Suspension formulations of insulinotropic peptides and uses thereof
DK2240155T3 (da)	2008-02-13	2012-09-17	Intarcia Therapeutics Inc	Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
LT2462246T (lt)	2009-09-28	2017-11-27	Intarcia Therapeutics, Inc	Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2013024156A2 (en)	2011-08-17	2013-02-21	INSERM (Institut National de la Santé et de la Recherche Médicale)	Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024158A1 (en)	2011-08-17	2013-02-21	INSERM (Institut National de la Santé et de la Recherche Médicale)	Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2014033266A1 (en)	2012-08-31	2014-03-06	INSERM (Institut National de la Santé et de la Recherche Médicale)	Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en)	2015-06-03	2021-02-23	Intarcia Therapeutics, Inc.	Implant placement and removal systems
EP3458084B1 (en)	2016-05-16	2020-04-01	Intarcia Therapeutics, Inc	Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
KR20190104039A (ko)	2017-01-03	2019-09-05	인타르시아 세라퓨틱스 인코포레이티드	Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2906160A1 (de) *	1979-02-17	1980-09-04	Thomae Gmbh Dr K	Verbessertes verfahren zur herstellung von humaninterferon
AU538665B2 (en) *	1979-10-30	1984-08-23	Juridical Foundation, Japanese Foundation For Cancer Research	Human interferon dna
IL58765A (en) *	1979-11-21	1986-09-30	Yeda Res & Dev	Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4530901A (en) *	1980-01-08	1985-07-23	Biogen N.V.	Recombinant DNA molecules and their use in producing human interferon-like polypeptides
CY1346A (en) *	1980-01-08	1987-01-16	Biogen Nv	Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides
GB2068970B (en) *	1980-02-06	1983-06-22	Searle & Co	Recombinant dna technique for the preparation of a protein resembling human interferon
DE3005843A1 (de) *	1980-02-16	1981-09-10	Hoechst Ag, 6000 Frankfurt	Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DE3005897A1 (de) *	1980-02-16	1981-09-03	Hoechst Ag, 6000 Frankfurt	Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
ES506955A0 (es) *	1980-11-10	1983-02-01	Genentech Inc	Un procedimiento para producir un polipeptido antiviral.
DE3106982A1 (de) *	1981-02-25	1982-09-09	Dr. Karl Thomae Gmbh, 7950 Biberach	"neues tridecadeoxynukleotid, verfahren zu seiner herstellung und verwendung"
IL63327A (en) *	1981-07-16	1985-11-29	Yeda Res & Dev	Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria
GB2108510B (en) *	1981-10-03	1984-12-12	Ciba Geigy Ag	Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

1982
- 1982-05-28 DE DE19823220116 patent/DE3220116A1/de active Granted
1983
- 1983-05-19 US US06/495,944 patent/US4820638A/en not_active Expired - Fee Related
- 1983-05-23 FI FI831818A patent/FI82072C/fi not_active IP Right Cessation
- 1983-05-24 GR GR71447A patent/GR79236B/el unknown
- 1983-05-24 AT AT83105116T patent/ATE42114T1/de not_active IP Right Cessation
- 1983-05-24 EP EP83105116A patent/EP0095702B1/de not_active Expired
- 1983-05-24 DE DE8383105116T patent/DE3379591D1/de not_active Expired
- 1983-05-26 IL IL68790A patent/IL68790A/xx unknown
- 1983-05-26 DD DD83251287A patent/DD211359C4/de not_active IP Right Cessation
- 1983-05-27 SU SU833598429A patent/SU1346048A3/ru active
- 1983-05-27 NO NO831903A patent/NO168538C/no unknown
- 1983-05-27 ES ES522762A patent/ES8403522A1/es not_active Expired
- 1983-05-27 DK DK239383A patent/DK164742C/da not_active IP Right Cessation
- 1983-05-27 UA UA3598429A patent/UA8037A1/uk unknown
- 1983-05-27 AU AU15044/83A patent/AU565479B2/en not_active Ceased
- 1983-05-27 ZA ZA833845A patent/ZA833845B/xx unknown
- 1983-05-27 HU HU831890A patent/HU196452B/hu not_active IP Right Cessation
- 1983-05-27 JP JP58093886A patent/JPH0774238B2/ja not_active Expired - Lifetime
- 1983-05-27 NZ NZ204384A patent/NZ204384A/en unknown
- 1983-05-28 KR KR1019830002362A patent/KR920006349B1/ko not_active IP Right Cessation
1984
- 1984-02-01 ES ES529360A patent/ES8500321A1/es not_active Expired
1992
- 1992-04-07 SG SG386/92A patent/SG38692G/en unknown
- 1992-06-12 MX MX9202815A patent/MX9202815A/es unknown
1993
- 1993-03-22 JP JP5062065A patent/JP2558422B2/ja not_active Expired - Lifetime
- 1993-10-21 HK HK1128/93A patent/HK112893A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES529360A0 (es)	1984-10-01
NO168538B (no)	1991-11-25
DE3220116C2 (el)	1993-02-18
AU565479B2 (en)	1987-09-17
DK239383D0 (da)	1983-05-27
JPS5925689A (ja)	1984-02-09
ES8500321A1 (es)	1984-10-01
US4820638A (en)	1989-04-11
KR840004944A (ko)	1984-10-31
IL68790A0 (en)	1983-09-30
SU1346048A3 (ru)	1987-10-15
HK112893A (en)	1993-10-29
DK164742B (da)	1992-08-10
FI82072B (fi)	1990-09-28
NO831903L (no)	1983-11-29
DD211359A5 (de)	1984-07-11
ZA833845B (en)	1985-01-30
UA8037A1 (uk)	1995-12-26
JP2558422B2 (ja)	1996-11-27
NO168538C (no)	1992-03-04
HU196452B (en)	1988-11-28
MX9202815A (es)	1992-06-30
DD211359C4 (de)	1986-09-24
DE3379591D1 (en)	1989-05-18
ES522762A0 (es)	1984-03-16
AU1504483A (en)	1983-12-01
FI831818A0 (fi)	1983-05-23
JPH0678774A (ja)	1994-03-22
KR920006349B1 (ko)	1992-08-03
IL68790A (en)	1991-06-10
DK164742C (da)	1992-12-28
DK239383A (da)	1983-11-29
ATE42114T1 (de)	1989-04-15
EP0095702B1 (de)	1989-04-12
FI831818L (fi)	1983-11-29
DE3220116A1 (de)	1983-12-01
NZ204384A (en)	1986-11-12
EP0095702A1 (de)	1983-12-07
JPH0774238B2 (ja)	1995-08-09
SG38692G (en)	1992-09-04
FI82072C (fi)	1991-01-10
ES8403522A1 (es)	1984-03-16

Publication	Publication Date	Title
GR79236B (el)	1984-10-22
AU558966B2 (en)	1987-02-19	Interferon and amino acid as stabilizer
AU574323B2 (en)	1988-07-07	Yeast expression of interferon and other proteins
GB8610600D0 (en)	1986-06-04	Transformation of trichoderma
AU1152783A (en)	1983-07-28	Interferon alpha 76
IL78885A0 (en)	1986-09-30	Removal of the n-terminal methionine from methionyl proteins
GR3004556T3 (el)	1993-04-28
IL76194A (en)	1988-06-30	4,5-dihydro-4-oxo-2-((2-trans-phenyl cyclopropyl)amino)-3-furancarboxylic acids and derivatives
GB8414354D0 (en)	1984-07-11	Purifying protein
DE3664715D1 (en)	1989-09-07	Improved protein hydrolysate
DE3370543D1 (en)	1987-04-30	Process for the determination of interferon and kit for the assay of interferon
ATE50597T1 (de)	1990-03-15	Alpha-interferon gx-1.
EP0180737A3 (en)	1986-05-28	Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
AU1152983A (en)	1983-07-28	Interferon alpha 74
DE3782006D1 (en)	1992-11-05	Peptide.
IL86153A0 (en)	1988-11-15	Recombinant htlv-iii proteins and uses thereof
CS485783A2 (en)	1985-06-13	Zpusob vyroby 1 ethoxykarbonyloxyethylesteru kyseliny 6 (d ( ) alfa amino alfa fenylacetoamido)penicilanove
GB8511710D0 (en)	1985-06-19	N-benzyloxycarbonyl amino acids
IL96513A0 (en)	1991-08-16	Polypeptide comprising the amino acid sequence of recombinant human immune interferon
IN156668B (el)	1985-10-12
CS160983A2 (en)	1990-09-12	Method of polypetide production with sequence of animal interferon's amino acids
ZA883261B (en)	1988-12-06	Recombinant htlv-iii proteins and uses thereof
GB8628051D0 (en)	1986-12-31	Tiamulin pamoate
AU1109583A (en)	1983-07-28	Interferon alpha 61